These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 32866323)
1. Chilblains and COVID-19: further evidence against a causal association. Baeck M; Peeters C; Herman A J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):e2-e3. PubMed ID: 32866323 [No Abstract] [Full Text] [Related]
2. Are SARS-CoV-2 IgA antibodies in paediatric patients with chilblain-like lesions indicative of COVID-19 asymptomatic or paucisymptomatic infection? Diociaiuti A; Giancristoforo S; Terreri S; Corbeddu M; Concato C; Ciofi Degli Atti M; Zambruno G; Carsetti R; El Hachem M J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):e10-e13. PubMed ID: 32920919 [No Abstract] [Full Text] [Related]
3. Paraviral eruptions in the era of COVID-19: Do some skin manifestations point to a natural resistance to SARS-CoV-2? Lipsker D Clin Dermatol; 2020; 38(6):757-761. PubMed ID: 33341210 [TBL] [Abstract][Full Text] [Related]
4. Pediatric COVID toes and fingers. Koschitzky M; Oyola RR; Lee-Wong M; Abittan B; Silverberg N Clin Dermatol; 2021; 39(1):84-91. PubMed ID: 33972057 [TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 spike protein is present in both endothelial and eccrine cells of a chilblain-like skin lesion. Gambichler T; Reuther J; Stücker M; Stranzenbach R; Torres-Reyes C; Schlottmann R; Schmidt WE; Hayajneh R; Sriram A; Becker JC J Eur Acad Dermatol Venereol; 2021 Mar; 35(3):e187-e189. PubMed ID: 33002210 [TBL] [Abstract][Full Text] [Related]
6. Discordant anti-SARS-CoV-2 spike protein and RNA staining in cutaneous perniotic lesions suggests endothelial deposition of cleaved spike protein. Ko CJ; Harigopal M; Gehlhausen JR; Bosenberg M; McNiff JM; Damsky W J Cutan Pathol; 2021 Jan; 48(1):47-52. PubMed ID: 32895985 [TBL] [Abstract][Full Text] [Related]
7. COVID toes: where do we stand with the current evidence? Baeck M; Herman A Int J Infect Dis; 2021 Jan; 102():53-55. PubMed ID: 33075530 [TBL] [Abstract][Full Text] [Related]
8. Lack of association between pandemic chilblains and SARS-CoV-2 infection. Gehlhausen JR; Little AJ; Ko CJ; Emmenegger M; Lucas C; Wong P; Klein J; Lu P; Mao T; Jaycox J; Wang E; ; Ugwu N; Muenker C; Mekael D; Klein RQ; Patrignelli R; Antaya R; McNiff J; Damsky W; Kamath K; Shon J; Ring AM; Yildirim I; Omer S; Ko AI; Aguzzi A; Iwasaki A Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35217624 [TBL] [Abstract][Full Text] [Related]
9. A clinicopathological description of COVID-19-induced chilblains (COVID-toes) correlated with a published literature review. Kolivras A; Thompson C; Pastushenko I; Mathieu M; Bruderer P; de Vicq M; Feoli F; Harag S; Meiers I; Olemans C; Sass U; Dehavay F; Fakih A; Lam-Hoai XL; Marneffe A; Van De Borne L; Vandersleyen V; Richert B J Cutan Pathol; 2022 Jan; 49(1):17-28. PubMed ID: 34272741 [TBL] [Abstract][Full Text] [Related]
10. Increased Intracranial Pressure in the Setting of Multisystem Inflammatory Syndrome in Children, Associated With COVID-19. Baccarella A; Linder A; Spencer R; Jonokuchi AJ; King PB; Maldonado-Soto A; Boneparth A; Hooe BS; Schweickert AJ; Carlin RF; Kingery F; Vargas WS; Sewell TB; Silver WG Pediatr Neurol; 2021 Feb; 115():48-49. PubMed ID: 33333460 [No Abstract] [Full Text] [Related]
15. Dynamics of viral load and anti-SARS-CoV-2 antibodies in patients with positive RT-PCR results after recovery from COVID-19. Song KH; Kim DM; Lee H; Ham SY; Oh SM; Jeong H; Jung J; Kang CK; Park JY; Kang YM; Kim JY; Park JS; Park KU; Kim ES; Kim HB Korean J Intern Med; 2021 Jan; 36(1):11-14. PubMed ID: 32972123 [TBL] [Abstract][Full Text] [Related]
16. Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies. Tré-Hardy M; Wilmet A; Beukinga I; Favresse J; Dogné JM; Douxfils J; Blairon L J Med Virol; 2021 Feb; 93(2):803-811. PubMed ID: 32667733 [TBL] [Abstract][Full Text] [Related]
17. Immunological and virological profile of children with chilblain-like lesions and SARS-CoV-2. Fertitta L; Welfringer-Morin A; Ouedrani A; Polivka L; Chhun S; Chatenoud L; Fourgeaud J; Hadj-Rabia S; Temmam S; Eloit M; Sermet-Gaudelus I; Bodemer C J Eur Acad Dermatol Venereol; 2021 Mar; 35(3):e164-e167. PubMed ID: 33010072 [No Abstract] [Full Text] [Related]
18. Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic. Stavert R; Meydani-Korb A; de Leon D; Osgood R; Blau J; Luu T J Am Acad Dermatol; 2020 Dec; 83(6):1753-1755. PubMed ID: 32822790 [No Abstract] [Full Text] [Related]